Open Access

Proliferative multifocal leukoplakia better name that proliferative verrucous leukoplakia

World Journal of Surgical Oncology20119:122

https://doi.org/10.1186/1477-7819-9-122

Received: 5 April 2011

Accepted: 10 October 2011

Published: 10 October 2011

Abstract

In this letter I propose the name "Proliferative Multifocal Leukoplakia" with the goal of reducing under-diagnosis of this disease, improve the early diagnosis, try to make an early therapy and control, and prevent its malignant transformation.

Correspondence

Dear Editor,

It has recently been published in World Journal of Surgical Oncology a progressive case report of the still enigmatic process "Proliferative Verrucous Leukoplakia" (PVL) [1].

Since the first description by Hansen et al. [2] of these oral premalignant disorder, the "verrucous appearance" seemed to be a key semiological data for the diagnosis of this particular disease that still has many unresolved issues in relation to its pathogenesis, diagnosis and treatment [3, 4].

Several series of cases of PVL proving in an unchallengeable manner their high premalignant capacity have been published [57]. Furthermore, these series of cases have also shown that the premalignat capacity of PVL is even higher than the one observed in "common leukoplakias". Therefore, the early diagnosis of this pathology plays a crucial role when trying to prevent a malignant transformation in PVL or at least when trying to prevent de development of extensive carcinomas. Typically many of the cases described in the literature have been diagnosed in a retrospective fashion, including the initial study of Hansen et al. [2].

In a recently published review article [8], major and minor diagnostic criteria have been proposed for diagnosing PVL, including "the presence of a verrucous area" between the major diagnostic criteria.

To our knowledge, we believe that this criteria should not be consider a major criteria in this disease, since in many cases the initial lesions are not warty, and when they finally have a verrucous appearance, they histologically correspond to verrucous carcinomas [4, 7, 8]. Therefore, if you consider the verrucous appearance as a major criterion, the diagnosis of this disease may happen to be delayed.

For my experience, I believe that the most important diagnostic criteria for this type of leukoplakia, which should be recognized early, are its "proliferate" and "multifocal" nature. The proliferative nature of this oral pathology would conditioned by the following elements: the existence of multiple leukoplakias (more than 2 locations), registering the clinical growth of the lesions and the relapse of previously treated areas in a suitable way. Logically, the performance and assessment of representative biopsies is essential to establish the existence of epithelial dysplasia or a carcinoma.

These considerations are in agreement with the views of other authors such as Saito et al. [9] and Hamadah et al. [10], who pointed out that "widespread multiple oral lesions" were the ones with a greater malignant potential when compared with the ones which were localized and unique.

Therefore, I propose the name "Proliferative Multifocal Leukoplakia" for this disease with the goal of reducing under-diagnosis, improve the early diagnosis, try to make an early therapy and control, and prevent its malignant transformation.

Declarations

Acknowledgements

None

Authors’ Affiliations

(1)
Oral Medicine Unit, Oral and Maxillofacial Pathology Unit, Dental Clinic Service. Department of Stomatology, University of the Basque Country/EHU, Barrio Sarriena s/n

References

  1. Ge L, Wu Y, Wu LY, Zhang L, Xie B, Zeng X, Lin M, Zhou HM: Case report of rapidly progressive proliferative verrucous leukoplakia and a proposal for aetiology in mainland China. World J Surg Oncol. 2011, 9: 26-10.1186/1477-7819-9-26.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Hansen LS, Olson JA, Silverman S: Proliferative verruocus leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985, 60: 285-98. 10.1016/0030-4220(85)90313-5.View ArticlePubMedGoogle Scholar
  3. van der Waal I, Reichart PA: Oral proliferative verrucous leukoplakia revisited. Oral Oncol. 2008, 44: 719-21. 10.1016/j.oraloncology.2007.09.010.View ArticlePubMedGoogle Scholar
  4. Bagan J, Scully C, Jimenez Y, Martorell M: Proliferative verrucous leukoplakia: a concise update. Oral Dis. 2010, 16: 328-32. 10.1111/j.1601-0825.2009.01632.x.View ArticlePubMedGoogle Scholar
  5. Zakrzewska JM, Lopes V, Speight P, Hopper C: Proliferative verrucous leukoplakia: a report of ten cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996, 82: 396-401. 10.1016/S1079-2104(96)80303-9.View ArticlePubMedGoogle Scholar
  6. Silverman S, Gorsky M: Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997, 84: 154-7. 10.1016/S1079-2104(97)90062-7.View ArticlePubMedGoogle Scholar
  7. Bagan JV, Jimenez Y, Sanchis JM, Poveda R, Milian MA, Murillo J, Scully C: Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med. 2003, 32: 379-82. 10.1034/j.1600-0714.2003.00167.x.View ArticlePubMedGoogle Scholar
  8. Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA, Esparza-Gómez G, Bagán JV: Proliferative verrucous leukoplakia: a proposal for diagnostic criteria. Med Oral Pat Oral Cir Bucal. 2010, 15: 839-45.View ArticleGoogle Scholar
  9. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Kohgo T, Fukuda H: High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis. 1999, 5: 15-9.View ArticlePubMedGoogle Scholar
  10. Hamadah O, Goodson ML, Thomson PJ: Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions. Br J Oral Maxillofac Surg. 2010, 48: 503-6. 10.1016/j.bjoms.2009.08.027.View ArticlePubMedGoogle Scholar

Copyright

© Aguirre-Urizar; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement